News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
412,575 Results
Type
Article (27729)
Company Profile (115)
Press Release (384727)
Multimedia
Podcasts (66)
Webinars (12)
Section
Business (102277)
Career Advice (545)
Deals (18043)
Drug Delivery (91)
Drug Development (38939)
Employer Resources (80)
FDA (10905)
Job Trends (10029)
News (176075)
Policy (20867)
Tag
2027 Biotech Bay Standard (1)
2027 Genetown Elite (1)
2027 Pharm Country Standard (3)
Academia (2122)
Academic (2)
Accelerated approval (21)
Adcomms (16)
Allergies (94)
Alliances (28680)
ALS (88)
Alzheimer's disease (1111)
Antibody-drug conjugate (ADC) (149)
Approvals (11215)
Artificial intelligence (363)
Autoimmune disease (83)
Automation (20)
Bankruptcy (148)
Best Places to Work (9005)
BIOSECURE Act (8)
Biosimilars (156)
Biotechnology (58)
Bladder cancer (103)
Brain cancer (35)
Breast cancer (358)
Cancer (2549)
Cardiovascular disease (289)
Career advice (508)
Career pathing (14)
CAR-T (117)
CDC (51)
Cell therapy (365)
Cervical cancer (26)
Clinical research (34100)
Collaboration (1064)
Compensation (148)
Complete response letters (22)
COVID-19 (2305)
CRISPR (52)
C-suite (506)
Cystic fibrosis (88)
Data (3760)
Decentralized trials (2)
Denatured (21)
Depression (108)
Diabetes (342)
Diagnostics (5165)
Digital health (45)
Diversity (10)
Diversity, equity & inclusion (24)
Drug discovery (138)
Drug pricing (169)
Drug shortages (12)
Duchenne muscular dystrophy (127)
Earnings (36245)
Editorial (40)
Employer branding (8)
Employer resources (73)
Events (76255)
Executive appointments (661)
FDA (13075)
Fibrodysplasia Ossificans Progressiva (6)
Friedreich's ataxia (5)
Frontotemporal dementia (15)
Funding (1038)
Gene editing (99)
Generative AI (34)
Gene therapy (289)
GLP-1 (593)
Government (4391)
Grass and pollen (6)
Guidances (284)
Healthcare (15088)
HIV (53)
Huntington's disease (18)
IgA nephropathy (49)
Immunology and inflammation (113)
Immuno-oncology (29)
Indications (73)
Infectious disease (2549)
Inflammatory bowel disease (124)
Inflation Reduction Act (16)
Influenza (109)
Intellectual property (114)
Interviews (59)
IPO (7786)
IRA (40)
Job creations (1412)
Job search strategy (450)
JPM (60)
Kidney cancer (4)
Labor market (39)
Layoffs (212)
Leadership (11)
Legal (3939)
Liver cancer (57)
Longevity (12)
Lung cancer (314)
Lymphoma (203)
Machine learning (20)
Management (30)
Manufacturing (409)
MASH (106)
Medical device (9628)
Medtech (9672)
Mergers & acquisitions (10936)
Metabolic disorders (852)
Multiple sclerosis (113)
NASH (10)
Neurodegenerative disease (186)
Neuropsychiatric disorders (61)
Neuroscience (1889)
Neurotech (1)
NextGen: Class of 2026 (4994)
Non-profit (3950)
Now hiring (13)
Obesity (393)
Opinion (159)
Ovarian cancer (80)
Pain (111)
Pancreatic cancer (90)
Parkinson's disease (158)
Partnered (21)
Patents (220)
Patient recruitment (281)
Peanut (32)
People (33697)
Pharmaceutical (31)
Pharmacy benefit managers (29)
Phase 1 (10799)
Phase 2 (13398)
Phase 3 (12128)
Pipeline (3370)
Policy (242)
Postmarket research (1574)
Preclinical (3463)
Press Release (47)
Prostate cancer (144)
Psychedelics (38)
Radiopharmaceuticals (170)
Rare diseases (536)
Real estate (2878)
Recruiting (33)
Regulatory (15602)
Reports (25)
Research institute (1967)
Resumes & cover letters (40)
Rett syndrome (20)
RNA editing (6)
RSV (65)
Schizophrenia (108)
Series A (162)
Series B (135)
Service/supplier (4)
Sickle cell disease (73)
Special edition (11)
Spinal muscular atrophy (95)
Sponsored (28)
Startups (2115)
Stomach cancer (4)
Supply chain (71)
Tariffs (47)
The Weekly (44)
Vaccines (851)
Venture capital (67)
Weight loss (239)
Women's health (84)
Worklife (7)
Date
Today (81)
Last 7 days (384)
Last 30 days (1381)
Last 365 days (18715)
2026 (2019)
2025 (19044)
2024 (21778)
2023 (24258)
2022 (33694)
2021 (37134)
2020 (37570)
2019 (33254)
2018 (24878)
2017 (17708)
2016 (18859)
2015 (21431)
2014 (16060)
2013 (12721)
2012 (13464)
2011 (13906)
2010 (11929)
Location
Africa (531)
Alabama (35)
Alaska (6)
Arizona (184)
Arkansas (11)
Asia (22432)
Australia (3970)
California (6215)
Canada (2183)
China (614)
Colorado (307)
Connecticut (334)
Delaware (192)
Europe (50450)
Florida (991)
Georgia (262)
Hawaii (2)
Idaho (39)
Illinois (602)
India (56)
Indiana (453)
Iowa (13)
Japan (297)
Kansas (89)
Kentucky (27)
Louisiana (24)
Maine (79)
Maryland (949)
Massachusetts (4602)
Michigan (220)
Minnesota (401)
Mississippi (3)
Missouri (121)
Montana (18)
Nebraska (20)
Nevada (93)
New Hampshire (59)
New Jersey (2167)
New Mexico (12)
New York (1955)
North Carolina (969)
North Dakota (4)
Northern California (3106)
Ohio (220)
Oklahoma (13)
Oregon (28)
Pennsylvania (1438)
Puerto Rico (12)
Rhode Island (29)
South America (681)
South Carolina (34)
South Dakota (1)
Southern California (2354)
Tennessee (139)
Texas (945)
United States (24556)
Utah (265)
Virginia (144)
Washington D.C. (53)
Washington State (602)
West Virginia (3)
Wisconsin (89)
Wyoming (2)
412,575 Results for "jaguar health".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Jaguar Health Awarded $240,000 FDA Grant in Support of Canalevia-CA1 for Treatment of Chemotherapy-Induced Diarrhea (CID) in Dogs
January 5, 2026
·
6 min read
Press Releases
FDA Approves Renewal of Canalevia-CA1, Jaguar Health’s Drug for Chemotherapy-Induced Diarrhea (CID) in Dogs
December 11, 2025
·
7 min read
Press Releases
Jaguar Health Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - October 24, 2025
October 27, 2025
·
3 min read
Press Releases
Jaguar Health Reports Third Quarter 2025 Financials: Net Q3 2025 Revenue Up Approximately 4% Versus Net Q2 2025 Revenue
November 18, 2025
·
11 min read
Press Releases
Jaguar Health Completes Meeting with FDA for Advice on Development Pathways to Advance Ongoing Crofelemer Trial for Potential Approval for Treatment of Pediatric Indication Microvillus Inclusion Disease (MVID)
October 7, 2025
·
5 min read
Press Releases
Jaguar Health Presenting September 25 at Emerging Growth Conference and September 30 at Lytham Partners Fall 2025 Conference to Provide Updates on Near-Term Catalysts
September 24, 2025
·
3 min read
Press Releases
Jaguar Health Presenting at September 8-10 H.C. Wainwright Annual Global Investment Conference to Provide Updates on Near-Term Catalysts
September 8, 2025
·
3 min read
Press Releases
Jaguar Health Receives Notice of $250,000 FDA Grant to Fund Confirmatory Trial to Support FDA Approval of Canalevia for Treatment of Chemotherapy-Induced Diarrhea (CID) in Dogs
September 26, 2025
·
10 min read
Press Releases
FDA-Authorized Expanded Access Programs Utilizing Jaguar Health’s Novel Crofelemer Powder for Oral Solution to Treat Two Pediatric Intestinal Failure Patients with Microvillus Inclusion Disease
October 1, 2025
·
6 min read
Press Releases
Jaguar Health Submits Orphan Drug Designation Application to FDA for Crofelemer for Cancer Therapy-Related Diarrhea (CTD) in Patients with Breast Cancer with Metastasis Identified by FDA as a Distinct Condition
September 25, 2025
·
4 min read
1 of 41,258
Next
